Edgewise Therapeutics Inc... (EWTX)

AI Score

Unlock

13.57

0.27 (2.03%)

At close: Apr 22, 2025, 3:59 PM

Edgewise Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	41.67M	44.81M	43.48M	30.26M	86.1M	32.96M	31.81M	48.23M	21.99M	109.75M	18.34M	34.45M	15.57M	10.57M	50.4M	221.04M	104.92M	-23.65M
Short-Term Investments	428.5M	447.73M	468.27M	502.5M	232.3M	256.74M	278.12M	279.72M	329.95M	255.07M	230.05M	231.38M	265.22M	279.91M	248.75M	88.83M	24.18M	47.31M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	262K	262K	262K	n/a	348K	467K	419K	5.66M	251K	264K	447K	559K	548K	295K	n/a	201K	975K	-23.65M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	5.31M	6.9M	7.69M	8.67M	8.6M	8.22M	7.07M	5.41M	5.05M	5.32M	4.95M	n/a	2.98M	2.76M	3.82M	674K	n/a	n/a
Total Current Assets	475.48M	499.44M	519.44M	541.43M	327M	297.92M	317M	327.95M	357M	370.14M	253.34M	268.62M	283.77M	293.24M	302.97M	310.55M	129.65M	23.65M
Property-Plant & Equipment	11.07M	11.58M	11.94M	12.38M	12.69M	12.98M	13.21M	12.79M	9.85M	6.75M	3.61M	3.57M	912K	911K	524K	499K	516K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	11.33M	11.85M	12.21M	12.38M	13.04M	13.44M	13.63M	18.45M	10.1M	7.01M	4.06M	4.13M	1.46M	1.21M	524K	700K	1.49M	-23.65M
Total Assets	486.82M	511.28M	531.65M	553.81M	340.04M	311.36M	330.63M	346.4M	367.1M	377.15M	257.4M	272.75M	285.23M	294.45M	303.49M	311.25M	131.14M	n/a
Account Payables	5.58M	5.65M	6.8M	4.72M	4.03M	5.32M	3.78M	3.88M	6.11M	5.76M	2.83M	5.34M	3.84M	2.29M	2.82M	1.62M	1.58M	n/a
Deferred Revenue	n/a	n/a	-988K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	988K	n/a	980K	931K	872K	n/a	608K	216K	104K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	10.06M	6.18M	4.16M	n/a	5.09M	4.75M	5.75M	0.00	5.23M	4.42M	4.16M	n/a	n/a	n/a	n/a	408K	452K	n/a
Total Current Liabilities	23.86M	18.96M	17.18M	14.6M	16.77M	16.34M	14.4M	12.71M	16.59M	13.3M	9.22M	10M	10.52M	8.75M	6.74M	4.85M	4.34M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	59K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	192K	187K	329K	295K	n/a	n/a	160.21M	n/a
Total Long-Term Liabilities	3.74M	3.45M	4M	4.26M	4.43M	4.6M	4.77M	4.84M	3.8M	2.45M	1.83M	2.38M	329K	295K	n/a	n/a	160.21M	n/a
Total Liabilities	27.6M	22.41M	21.17M	18.86M	21.2M	20.94M	19.17M	17.56M	20.39M	15.75M	11.04M	12.39M	10.85M	9.05M	6.74M	4.85M	164.56M	n/a
Total Debt	4.74M	4.44M	4.99M	5.25M	5.41M	5.53M	5.64M	5.64M	4.41M	2.66M	1.74M	2.2M	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	9K	9K	9K	9K	7K	6K	6K	6K	6K	6K	5K	5K	5K	5K	5K	5K	n/a	n/a
Retained Earnings	-378.58M	-338.91M	-304.79M	-273.29M	-244.76M	-214.62M	-188.91M	-167.44M	-144.6M	-125.19M	-107.69M	-91.62M	-76.96M	-64.26M	-51.31M	-40.96M	-34.15M	n/a
Comprehensive Income	420K	1.05M	-1.05M	-861K	99K	-424K	-547K	-251K	-1.35M	-2.18M	-2.34M	-1.93M	-514K	-24K	-33K	-54K	n/a	-16.85M
Shareholders Equity	459.22M	488.88M	510.47M	534.94M	318.83M	290.43M	311.45M	328.84M	346.72M	361.4M	246.35M	260.36M	274.38M	285.4M	296.75M	306.39M	-33.42M	23.41M
Total Investments	428.5M	447.73M	468.27M	502.5M	232.3M	256.74M	278.12M	279.72M	329.95M	255.07M	230.05M	231.38M	265.22M	279.91M	248.75M	88.83M	24.18M	47.31M